Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$4.6 - $10.21 $139,522 - $309,679
-30,331 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$6.59 - $38.71 $49,912 - $293,189
-7,574 Reduced 19.98%
30,331 $204,000
Q2 2021

Aug 16, 2021

BUY
$32.1 - $57.78 $651,726 - $1.17 Million
20,303 Added 115.34%
37,905 $1.51 Million
Q1 2021

May 17, 2021

BUY
$42.5 - $75.37 $373,532 - $662,426
8,789 Added 99.73%
17,602 $879,000
Q4 2020

Nov 19, 2021

SELL
$33.49 - $57.94 $20,127 - $34,821
-601 Reduced 6.38%
8,813 $440,000
Q4 2020

Feb 18, 2021

BUY
$33.49 - $57.94 $315,274 - $545,447
9,414 New
9,414 $470,000

Others Institutions Holding EAR

About Eargo, Inc.


  • Ticker EAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 39,411,000
  • Market Cap $2.78B
  • Description
  • Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...
More about EAR
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.